Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.

Oncology reports - 1 Mar 2009

Zhang Xia, Tsukamoto Tetsuya, Mizoshita Tsutomu, Ban Hisayo, Suzuki Hidenori, Toyoda Takeshi, Tatematsu Masae

Abstract excerpt

We have investigated the expression of osteopontin (OPN) and CDX2 in advanced gastric cancers, and analyzed correlations with clinicopathological features to assess their prognostic potential. One-hundred and nine patients suffering from gastric cancer were recruited. Expression of OPN and CDX2 and other molecular markers was determined by immunohistochemistry. The total positive rate for OPN expression was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to CDX2 Transcription Factor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Homeodomain Proteins

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Osteopontin

Share to Stomach Neoplasms

Source

Identifiers

PMID: 19212618

Genes

CDX2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.PMID 19212618Read ↗

CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.Semantic proximity Read ↗

Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.Semantic proximity Read ↗

Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.Semantic proximity Read ↗

Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas.Semantic proximity Read ↗

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.Semantic proximity Read ↗

CDX2 is involved in microRNA‑associated inflammatory carcinogenesis in gastric cancerSemantic proximity Read ↗

New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.Semantic proximity Read ↗

The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.Semantic proximity Read ↗

Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.Semantic proximity Read ↗

Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells.Semantic proximity Read ↗

CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.Semantic proximity Read ↗

Nuclear transcription factor CDX2 inhibits gastric cancer‑cell growth and reverses epithelial‑to‑mesenchymal transition in vitro and in vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.